Ibrahim Ashraf S, Spellberg Brad J, Avanesian Valentina, Fu Yue, Edwards John E
Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 W. Carson St., Torrance, CA 90502, USA.
Infect Immun. 2006 May;74(5):3039-41. doi: 10.1128/IAI.74.5.3039-3041.2006.
We have previously shown that vaccination with a vaccine based on the recombinant N-terminal domain of Als1p (rAls1p-N) protected BALB/c mice against disseminated infection caused by a single strain of Candida albicans (A. S. Ibrahim, B. J. Spellberg, V. Avenissian, Y. Fu, S. G. Filler, and J. E. Edwards, Jr., Infect. Immun. 73:999-1005, 2005, and B. J. Spellberg, A. S. Ibrahim, V. Avenissian, S. G. Filler, C. Myers, Y. Fu, and J. E. Edwards, Jr., Infect. Immun. 73:6191-6193, 2005). Here we show that the rAls1p-N vaccine also improves survival of outbred mice from disseminated candidiasis and that it is active against multiple virulent strains of C. albicans and non-C. albicans spp.
我们之前已经表明，用基于Als1p重组N端结构域的疫苗（rAls1p-N）对BALB/c小鼠进行免疫接种，可保护其免受由单一白色念珠菌菌株引起的播散性感染（A.S.易卜拉欣、B.J.斯佩尔伯格、V.阿韦尼西安、Y.傅、S.G.菲勒和J.E.爱德华兹，《感染与免疫》73:999-1005，2005年；以及B.J.斯佩尔伯格、A.S.易卜拉欣、V.阿韦尼西安、S.G.菲勒、C.迈尔斯、Y.傅和J.E.爱德华兹，《感染与免疫》73:6191-6193，2005年）。在此我们表明，rAls1p-N疫苗还可提高远交系小鼠从播散性念珠菌病中的存活率，并且它对多种白色念珠菌和非白色念珠菌的毒力菌株均有活性。
